Delivery Order SPE2DB24D2100-SPE2DB24FBBAH
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $5,184.33 firm fixed-price contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The delivery order has a ceiling value of $22,501.20 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corporation is the prime contractor, and no set-aside was used for this award. The company also holds an Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,222.54 firm fixed-price contract is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a firm fixed price delivery order valued at $47,580.86, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a firm fixed price delivery order contract worth $7,942.04 to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The order has a firm fixed price of $13,868.20 and a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,647.20 firm fixed-price contract is for the provision of VAXNEUVANCE 0.5 ML syringes, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML medical product. The contract has a ceiling value of $12,734.82 and a completion date of November 21, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation noted. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $2,647.20, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products and has an ultimate completion date of April 3, 2024. This award is a child contract under a larger indefinite...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $9,615.20, is for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBBAHDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $23,276.39 and a period of performance through April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract was awarded on a full and open competition basis without a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 4/18/24 |